Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiedu Pingchan Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for the treatment of Parkinson's disease. It is part of a stage-based therapeutic strategy derived from the academic experience of Cheng Menxue and Ding's Internal Medicine. Specifically, Jiedu Pingchan is utilized during the middle to advanced stages of the disease, where "toxin" (Jie Du) is identified as a primary pathological factor according to TCM theory. It is typically administered as an oral decoction or granule formulation in combination with standard Western therapies, such as levodopa, to alleviate motor symptoms and improve patient quality of life.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiedu pingchan decoction.